Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-01-07 @ 11:28 AM
Study NCT ID:
NCT00862134
Status:
TERMINATED
Last Update Posted:
2013-01-10
First Post:
2009-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Proacta, Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-12
First Submit QC Date:
None
Study First Post Date:
2009-03-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-31
Results First Submit QC Date:
None
Results First Post Date:
2013-01-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-08
Last Update Post Date:
2013-01-10
Last Update Post Date Type:
ESTIMATED